TELA Bio
Stock Forecast, Prediction & Price Target
TELA Bio Financial Estimates
TELA Bio Revenue Estimates
TELA Bio EBITDA Estimates
TELA Bio Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $29.46M N/A | $41.41M 40.57% | $58.45M 41.12% | Avg: $95.65M Low: $92.43M High: $98.87M avg. 63.64% | Avg: $123.17M Low: $120.62M High: $126.01M avg. 28.77% | Avg: $160.05M Low: $156.73M High: $163.72M avg. 29.93% | Avg: $203.81M Low: $199.59M High: $208.49M avg. 27.34% |
Net Income
% change YoY
| $-36.11M N/A | $-44.33M -22.78% | $-46.66M -5.24% | Avg: $-34.47M Low: $-32.47M High: $-22.18M avg. 26.11% | Avg: $-13.70M Low: $-12.71M High: $-12.01M avg. 60.23% | Avg: $20.35M Low: $19.80M High: $20.96M avg. 248.47% | Avg: $48.02M Low: $46.73M High: $49.45M avg. 135.95% |
EBITDA
% change YoY
| $-29.67M N/A | $-39.01M -31.46% | $-40.63M -4.14% | Avg: $-89.57M Low: $-92.59M High: $-86.55M avg. -120.45% | Avg: $-115.35M Low: $-118.00M High: $-112.96M avg. -28.77% | Avg: $-149.87M Low: $-153.32M High: $-146.77M avg. -29.93% | Avg: $-190.86M Low: $-195.24M High: $-186.90M avg. -27.34% |
EPS
% change YoY
| -$2.49 N/A | -$2.73 -9.63% | -$2.04 25.27% | Avg: -$1.24 Low: -$1.42 High: -$0.97 avg. 39.05% | Avg: -$0.54 Low: -$0.56 High: -$0.53 avg. 56.56% | Avg: $0.89 Low: $0.87 High: $0.92 avg. 264.81% | Avg: $2.1 Low: $2.04 High: $2.16 avg. 135.95% |
Operating Expenses
% change YoY
| $48.26M N/A | $66.05M 36.85% | $84.18M 27.45% | Avg: $141.70M Low: $136.92M High: $146.47M avg. 68.32% | Avg: $182.47M Low: $178.69M High: $186.67M avg. 28.77% | Avg: $237.09M Low: $232.18M High: $242.54M avg. 29.93% | Avg: $301.93M Low: $295.67M High: $308.86M avg. 27.34% |
FAQ
What is TELA Bio stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 117.69% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is -32.47M, average is -34.47M and high is -22.18M.
What is TELA Bio stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 37.42% in 2025-2028.
We have gathered data from 4 analysts. Their low revenue estimate is $92.43M, average is $95.65M and high is $98.87M.
What is TELA Bio stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 124.09% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$1.42, average is -$1.24 and high is $-0.97.
What is the best performing analyst?
In the last twelve months analysts have been covering TELA Bio stock. The most successful analyst is Kyle Rose.